New molecular targets in bone metastases-Reference-Cited by-同舟云学术

New molecular targets in bone metastases

Published:2010-11 Issue: Volume:36 Page:S6-S10
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Santini D.,Galluzzo S.,Zoccoli A.,Pantano F.,Fratto M.E.,Vincenzi B.,Lombardi L.,Gucciardino C.,Silvestris N.,Riva E.,Rizzo S.,Russo A.,Maiello E.,Colucci G.,Tonini G.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference38 articles.

1. Metastatic bone disease: clinical features, pathophysiology and treatment strategies;Coleman;Cancer Treat Rev,2001

2. Preparing the “soil”: the premetastatic niche;Kaplan;Cancer Res,2006

3. Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing;Jung;Bone,2006

4. Osteoblasts in prostate cancer metastasis to bone;Logothetis;Nat Rev Cancer,2005

5. MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL;Lynch;Cancer Cell,2005

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone metastasis scintigram generation using generative adversarial learning with multi‐receptive field learning and two‐stage training;Medical Physics;2024-09-03

2. Functionalized 2-Amino-4 H -1-Benzopyran-4-yl Phosphonate Scaffolds: Synthesis, Anticancer Evaluation and Computational Studies;Polycyclic Aromatic Compounds;2023-11-27

3. Segmentation of Metastasized Lesions in Bone Scintigrams Using U-Net++ with Attention Gate;2023 3rd International Conference on Neural Networks, Information and Communication Engineering (NNICE);2023-02-24

4. Current comprehensive understanding of denosumab (the RANKL neutralizing antibody) in the treatment of bone metastasis of malignant tumors, including pharmacological mechanism and clinical trials;Frontiers in Oncology;2023-02-13

5. What Are the Approaches to Pain in Skeletal Bone Disease?;Evidence-Based Practice of Palliative Medicine;2023